Hutch News

Hutch News

Stories tagged 'Transplant and Immunotherapy'

A new option for high-risk multiple myeloma?

Study of three-step treatment approach reopens question of donor bone marrow transplant

Nov. 9, 2017 | by Susan Keown / Fred Hutch News Service

A new study offers a clue for solving a long-standing controversy in multiple myeloma: namely, whether a bone marrow transplant from a donor could be beneficial for patients with this disease and, if so, for which patients.

View story >


First systematic study of infections after CAR T-cell therapy

“Benchmark” research could help reduce complications of emerging immunotherapy

Nov. 6, 2017 | by Susan Keown / Fred Hutch News Service

The first detailed study of infections after CAR T-cell therapy could help researchers improve the safety of this emerging type of genetically engineered cell therapy for cancer.

View story >


Dr. Stephanie Lee elected vice president of American Society of Hematology

Her one-year term will be followed by successive terms as president-elect and president

Nov. 1, 2017 | By Molly McElroy / Fred Hutch News Service

The American Society of Hematology has elected Dr. Stephanie Lee, a member of the Clinical Research Division at Fred Hutchinson Cancer Research Center, to be its vice president. The one-year term will begin after the 2017 ASH Annual Meeting Dec. 9–12 in Atlanta. It will be followed by successive one-year terms as president-elect and then as president. ASH announced the news Nov. 1.

View story >


Good News at Fred Hutch

Celebrating faculty and staff achievements

Oct. 26, 2017

Fred Hutch leader Dr. Gary Gilliland addressed lawmakers at a hearing to discuss NIH funding for biomedical research, particularly the role of a type of funding called facilities and administrative costs.

View story >


Science without borders

At Fred Hutch and other U.S. research centers, a global village works to cure cancer and other diseases

Oct. 16, 2017 | By Mary Engel / Fred Hutch Research Center

Fred Hutch, like other major U.S. cancer research centers, attracts top scientists from around the world working to cure cancer, HIV and other diseases

View story >


New insights into CAR T-cell therapy's potential side effects

Detailed study of cytokine release syndrome and neurologic toxicities could help make emerging cancer immunotherapies safer

Oct. 11, 2017 | By Fred Hutch staff

Detailed studies of two potential side effects of an emerging cancer immunotherapy could eventually help make this strategy, CAR T-cell therapy, safer for patients. The studies examined cytokine release syndrome and neurologic toxicities.

View story >



GIVE NOW &
SAVE LIVES

Support our quest for cures

Story Archive


Publications

Hutch Magazine
Our quarterly magazine

Annual Report
Fiscal year highlights

Science Spotlight
Monthly review of Center-authored papers



Fred Hutch News

        Get updates via email.